Search for: "General Produce, Inc." Results 441 - 460 of 7,349
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2023, 10:17 am by Kim Krawiec
Nor can patients share in any of the profits that research on their tissue might generate. [read post]
29 Jan 2023, 4:40 am by Frank Cranmer
Masterpiece Cakeshop again In Scardina v Masterpiece Cakeshop Inc (CO Ct App. [read post]
26 Jan 2023, 12:38 pm by Justin Chan
Less than 10% of those stops produced arrests or seizures of guns, drugs, or contraband. [read post]
24 Jan 2023, 4:44 pm by Thomas James
” Metro-Goldwyn-Mayer Studios Inc. v. [read post]
24 Jan 2023, 3:32 pm by Eugene Volokh
[VDARE partly complied with the subpoena, but later sued] in United States District Court for the Northern District of New York … [VDARE Foundation, Inc. v. [read post]
23 Jan 2023, 9:01 pm by renholding
The SEC recently proposed a set of sweeping equity market structure reforms across four rule proposals that would make highly significant changes to how national market system (NMS) stock orders are priced, executed and reported. [read post]
23 Jan 2023, 5:00 pm by Aaron Moss
This is likely the concept that plaintiffs’ complaint is latching onto when it asserts that the output produced by AI art tools is “necessarily” derivative of the dataset of preexisting copyrighted works. [read post]
23 Jan 2023, 10:37 am by Eric Barton
Compounding matters for SIS was the fact that SIS never produced any evidence at trial of its alleged lost profits. [read post]
22 Jan 2023, 3:30 am by Frank Cranmer
General Synod February 2023 On Friday, the Church of England published the papers for next month’s meeting iof its General Synod, in London on 6-9 February. [read post]
21 Jan 2023, 3:35 am by The Nourmand Law Firm, APC
The employee claims his former employer, Fox Digital Enterprises, Inc., eliminated his shifts as a finishing editor due to his age. [read post]
19 Jan 2023, 10:19 am by Zak Gowen
  A Washington, D.C. appeals court rejected a lawsuit by Novartis AG’s Sandoz Inc that could have given it the sole right to make a generic version of Sanofi S.A. [read post]
17 Jan 2023, 11:03 am by Paul King Jr
  The Board’s decision in Thryv, Inc. is only one recent—but significant—example of this initiative operating in full swing. [read post]